Mechanisms of therapeutic change after psychedelic treatment in OCD.
Psychiatry research – June 01, 2024
Source: PubMed
Summary
Breakthrough treatments combining psilocybin therapy and imagery techniques show promise for treatment-resistant OCD. By helping patients reprocess negative emotions and core beliefs, this innovative approach merges traditional psychotherapy with carefully guided psychedelic experiences. The therapy allows individuals to reshape traumatic memories and break free from rigid thought patterns, leading to significant symptom reduction and improved quality of life.
Abstract
Novel treatments are required for the 30-50% of individuals with obsessive-compulsive disorder (OCD) who remain resistant to first-line pharmacological and psychotherapeutic treatments. Recent pilot data suggest benefit from psilocybin-assisted psychotherapy (PAP) and from imagery rescripting (ImRs). We explore psychological mechanisms of change underpinning both interventions that appear to allow for reprocessing of negative emotions and core beliefs associated with past aversive events. A next critical step in PAP is the development of psychotherapeutic frameworks grounded in theory. We propose that basing PAP on an ImRs framework may provide synergistic benefits in symptom reduction, modification of core beliefs, and value-based living.